Off topic doe not apply to GNBT: Schwab has ann
Post# of 36564
(Total Views: 699)
Posted On: 12/19/2020 12:54:45 PM
Off topic doe not apply to GNBT:
Schwab has announced they will no longer allow purchase of certain OTC stocks by 1/31.
Here is the email I got:
Caveat Emptor securities set to liquidate-only by January 31, 2021
By January 31, 2021, Charles Schwab & Co., Inc. (“Schwab”) will restrict orders in Caveat Emptor designated OTC securities to liquidating trades only. Closing trades will continue to be allowed after this time.
Why is this change happening?
A Caveat Emptor security is a designation the OTC Markets Group places on a security after a determination was made surrounding the company that there may be potential risk to investors which may include:
• a potentially misleading or manipulative stock promotion,
• known investigation of fraudulent or criminal activity committed by the company or insiders
• regulatory trading suspensions or halts,
• disruptive or undisclosed corporate actions, and/or
• other reasons related to the public interest.
Caveat Emptor securities have the potential for illiquid and highly volatile conditions. A skull and crossbones icon is placed next to the stock symbol.
This might apply to Gene Biotherapeutics (CRXM) who is expected to file their Super 10-k to get up to date with the SEC any day. Generex purchased Excellagen from CRXM.
Edit: I alerted CRXM CEO. Says they are close to having filing done.
Schwab has announced they will no longer allow purchase of certain OTC stocks by 1/31.
Here is the email I got:
Caveat Emptor securities set to liquidate-only by January 31, 2021
By January 31, 2021, Charles Schwab & Co., Inc. (“Schwab”) will restrict orders in Caveat Emptor designated OTC securities to liquidating trades only. Closing trades will continue to be allowed after this time.
Why is this change happening?
A Caveat Emptor security is a designation the OTC Markets Group places on a security after a determination was made surrounding the company that there may be potential risk to investors which may include:
• a potentially misleading or manipulative stock promotion,
• known investigation of fraudulent or criminal activity committed by the company or insiders
• regulatory trading suspensions or halts,
• disruptive or undisclosed corporate actions, and/or
• other reasons related to the public interest.
Caveat Emptor securities have the potential for illiquid and highly volatile conditions. A skull and crossbones icon is placed next to the stock symbol.
This might apply to Gene Biotherapeutics (CRXM) who is expected to file their Super 10-k to get up to date with the SEC any day. Generex purchased Excellagen from CRXM.
Edit: I alerted CRXM CEO. Says they are close to having filing done.
(2)
(0)